News

The window for GLP-1 compounders to tap dance around the compounding ban is almost closed — and anyone still trying to squeeze through could end up with some bruised fingers. A federal court ruling has backed the FDA’s determination that shortages of Wegovy and Ozempic are officially over, setting up a sharp end to the era of legally available compounded GLP-1s.

Starting a GLP-1 journey can feel overwhelming — not just because of the medication, but because of the new language that comes with it....

In this guide, we’re cutting through the noise and calling out the most common GLP-1 myths for what they are—subjective and sometimes silly.

My first attempt to get Zepbound through LillyDirect at the discounted price felt like a triangulated game of "Who's On First?" I faced a...

Eli Lilly, the pharmaceutical giant, filed a sweeping set of lawsuits in federal court, accusing four telehealth startups—Mochi Health, Fella Health, Empower Pharmacy, and Henry Meds—of illegally selling off-brand, compounded versions of its blockbuster weight-loss and diabetes drugs, Zepbound and Mounjaro.

The battle over compounded versions of blockbuster weight-loss drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro,...

The landscape of diabetes and obesity management is on the cusp of a significant transformation, driven by the development of oral...

As demand for GLP-1 medications like Ozempic (semaglutide) continues to surge in the U.S., the Food and Drug Administration (FDA) and...